Diagnosis:
NET (neuroendocrine tumor) well differentiated (carcinoid tumor) of the appendix
• Appendiceal neuroendocrine tumors occur with an incidence of 2 million to 3 million per year, with a 2:1 female-male ratio.
• Most appendiceal neuroendocrine tumors are diagnosed incidentally during appendectomy (1% of appendectomies); they are not related to a specific clinical presentation. The diagnosis is associated with, but not related to, acute appendicitis. Most tumors are located at the tip of the appendix (60% to 75%) and do not induce obstruction.
• Immunohistochemical analysis with chromogranin A and synaptophysin antibodies helps to confirm the diagnosis.
• Prognosis is related to the size of the tumor, and a maximal diameter larger than 2 cm is the most important parameter for prognosis. Another parameter related to prognosis is the presence and extent of mesoappendiceal invasion (>3 mm).
• The surgical margins of the appendectomy specimen (R0/R1) must be reported clearly. If the resection margin is positive for a tumor, a right hemicolectomy is generally required.
• Goblet cell carcinoids are considered to represent a separate clinicopathologic entity, distinct from classic appendiceal neuroendocrine tumors and adenocarcinomas, with an uncertain histogenesis. They are more aggressive than classic neuroendocrine tumors and require a different diagnostic and therapeutic approach.
Klöppel G, Perren A, Heitz PU:
The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 2004;1014:13–27.
Deschamps L and Couvelard A: Endocrine tumors of the appendix: a pathologic review.
Archives of Pathology & Laboratory Medicine 2010 (June); Vol. 134, No. 6, pp. 871-875.